Genetic alteration due to inflammation or mutations in TP53 (Tumor Protein 53) and KRAS (Kirsten rat sarcoma viral oncogene homolog) genes and gut dysbiosis is thought to be the cause of IBD-associated CRC development [13]. The gene discussed is TP53; the disease is inflammatory bowel disease.